Clinical Trial Update: Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial register update for Amphotericin B Cystetic for Inhalation (ABCI) to be tested in healthy volunteers and people with cystic fibrosis; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Amphotericin B Cystetic for Inhalation (ABCI) (amphotericin B)

Snippet

Sponsor: Cystetic Medicines, Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: RECRUITING